Home › Upcoming votes › aTyr Pharma, Inc.
This meeting took place on October 16, 2026. aTyr Pharma, Inc. reported the official results on Form 8-K, filed October 16, 2026 (read it on EDGAR); they are listed below. How funds voted appears on the company page after funds file Form N-PX, by August 31 after the proxy season ends on June 30.
The deadline as the proxy statement states it: “vote prior to the Special Meeting (until 11:59 p.m. Eastern Time on October 15, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGARaTyr Pharma, Inc.: past votes
Ballot read from the proxy statement and checked. As listed in aTyr Pharma, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | REVERSE STOCK SPLIT | Board | For | — |
From aTyr Pharma, Inc.’s Form 8-K, filed May 6, 2025, for the meeting held May 1, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Paul Schimmel, Ph.D. | 99.5% | Elected |
| Elect Director: Sara L. Zaknoen, M.D. | 86% | Elected |
| 2. Ratification of the appointment of Ernst and Young LLP as the independent registered public accounting firm of the Company for the fiscal | 99.7% | — |
| 3. Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement | 98% | — |
| 4. Approval of an amendment to the 2015 Stock Plan | 99.3% | — |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. Approval of a series of alternate amendments to the Company's restated certificate of incorporation to effect, at the option of the Compa | 91% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.